Nivolumab
7 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment (NCT06931613) | St. Petersburg State Pavlov Medical University | 2022-06-01 |
| Safety of SBRT With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors and Melanoma (NCT04572451) | Yana Najjar | 2021-11-29 |
| A Study of Nivolumab +/- Docetaxel in Patients Previously Treated With Advanced or Metastatic NSCLC (NCT04023617) | Peking University Cancer Hospital & Institute | 2019-07-08 |
| Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program (NCT02933346) | Intergroupe Francophone de Cancerologie Thoracique | 2016-09-01 |
Track Nivolumab automatically
Every clearance here is in the API, with alerts when new ones post.